100 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Pacific Capital Wealth Advisors Inc.

Pacific Capital Wealth Advisors Inc. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, HoldingsChannel reports. The fund bought 100 shares of the healthcare conglomerate’s stock, valued at approximately $53,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Cherry Tree Wealth Management LLC boosted its position in shares of UnitedHealth Group by 14.3% in the fourth quarter. Cherry Tree Wealth Management LLC now owns 817 shares of the healthcare conglomerate’s stock worth $430,000 after purchasing an additional 102 shares during the period. Barlow Wealth Partners Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $16,645,000. Crestone Asset Management LLC raised its position in UnitedHealth Group by 5.4% in the 4th quarter. Crestone Asset Management LLC now owns 471 shares of the healthcare conglomerate’s stock worth $248,000 after purchasing an additional 24 shares during the period. Patrick M Sweeney & Associates Inc. bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $1,025,000. Finally, Sovereign Financial Group Inc. grew its stake in UnitedHealth Group by 6.3% in the fourth quarter. Sovereign Financial Group Inc. now owns 2,078 shares of the healthcare conglomerate’s stock worth $1,094,000 after purchasing an additional 124 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on UNH shares. Oppenheimer restated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Bank of America reiterated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, Piper Sandler upped their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Trading Up 1.3 %

Shares of UNH stock traded up $6.58 during mid-day trading on Tuesday, hitting $500.96. 3,395,758 shares of the company’s stock were exchanged, compared to its average volume of 4,378,167. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The stock has a 50-day simple moving average of $481.45 and a two-hundred day simple moving average of $511.98. The stock has a market cap of $460.92 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 1.43 and a beta of 0.55. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the prior year, the firm earned $6.26 EPS. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.